For decades, the medical approach to treating obesity in children was the wait-and-see approach. But a new Canadian guideline ...

German packaging and medical equipment maker Gerresheimer reported a drop in its organic core earnings on Friday, hit by ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an ...

WeightWatchers is planning to file for bankruptcy after failing to compete against the rise of ‘quick-fix’ weight loss tools, ...

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...

A study from the Arkansas Agricultural Experiment Station finds that GLP-1 medications, such as Ozempic and Wegovy, are ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...